Literature DB >> 30677395

Techniques to study phagocytosis and uptake of Leishmania tarentolae by J774 macrophages.

Gerald Geroldinger1, Marlene Rezk1, Rugaia Idris1, Victoria Gruber1, Matthias Tonner1, Rudolf Moldzio2, Katrin Staniek1, Lianet Monzote3, Lars Gille4.   

Abstract

Leishmaniasis is a vector borne parasitic disease affecting millions of people worldwide and is spreading into further areas because of global warming. The development of new active substances against these single-cell eukaryotic parasites is of great importance. Leishmania tarentolae promastigotes (LtP) are non-pathogenic for mammals and serve as model organisms for pathogenic Leishmania in basic research. However, it is important to refine methods to study the process of the infection of mammalian macrophages by LtP and pathogenic Leishmania. Important stages of the infection are phagocytosis by macrophages and multiplication of Leishmania amastigotes in the phagolysosome of macrophages. In this study, advanced methods using electron spin resonance (ESR) spectroscopy and genetically manipulated LtP were used to monitor the infection of adherent J774 macrophages with LtP. An ESR method was established to detect the formation of superoxide radicals directly in adherent J774 cells and to investigate the effect of LtP on this activity. J774 cells responded with a burst of superoxide radicals in the presence of phorbol myristate acetate as positive control. In contrast, challenging J774 cells with LtP resulted in a much lower burst of superoxide radicals. To facilitate LtP detection in the phagolysosome of J774 macrophages, LtP expressing enhanced green fluorescent protein (EGFP-LtP) were constructed. After different infection times with EGFP-LtP, the J774 cells were visualized by phase contrast microscopy and the cell number was determined. The intramacrophage Leishmania tarentolae amastigotes (LtA) expressing EGFP were detected by fluorescence microscopy and then counted with ImageJ. These experiments showed that LtP are taken up by J774 cells and form intraphagolysosomal amastigotes. LtA under our conditions multiplied intracellularly and were able to persist about 48 h in J774 cells. These experiments showed that ESR spectroscopy of attached macrophages and the use of the EGFP-LtP are suitable methods to study the initial phase of Leishmania infection in vitro.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Electron spin resonance; J774 macrophages; Leishmania tarentolae; Superoxide radicals

Mesh:

Substances:

Year:  2019        PMID: 30677395      PMCID: PMC7116466          DOI: 10.1016/j.exppara.2019.01.012

Source DB:  PubMed          Journal:  Exp Parasitol        ISSN: 0014-4894            Impact factor:   2.011


  28 in total

1.  Leishmania infantum: infection of macrophages in vitro with promastigotes.

Authors:  S Méndez; M Nell; J M Alunda
Journal:  Int J Parasitol       Date:  1996-06       Impact factor: 3.981

2.  Medium-throughput ESR detection of superoxide production in undetached adherent cells using cyclic nitrone spin traps.

Authors:  K Abbas; M Hardy; F Poulhès; H Karoui; P Tordo; O Ouari; F Peyrot
Journal:  Free Radic Res       Date:  2015-06-05

3.  Heme oxygenase-1 promotes the persistence of Leishmania chagasi infection.

Authors:  Nívea F Luz; Bruno B Andrade; Daniel F Feijó; Théo Araújo-Santos; Graziele Q Carvalho; Daniela Andrade; Daniel R Abánades; Enaldo V Melo; Angela M Silva; Cláudia I Brodskyn; Manoel Barral-Netto; Aldina Barral; Rodrigo P Soares; Roque P Almeida; Marcelo T Bozza; Valéria M Borges
Journal:  J Immunol       Date:  2012-03-28       Impact factor: 5.422

4.  Leishmania donovani lipophosphoglycan blocks NADPH oxidase assembly at the phagosome membrane.

Authors:  Robert Lodge; Tamsir O Diallo; Albert Descoteaux
Journal:  Cell Microbiol       Date:  2006-07-11       Impact factor: 3.715

5.  Phosphorylation of p47phox sites by PKC alpha, beta II, delta, and zeta: effect on binding to p22phox and on NADPH oxidase activation.

Authors:  Alexandre Fontayne; Pham My-Chan Dang; Marie-Anne Gougerot-Pocidalo; Jamel El-Benna
Journal:  Biochemistry       Date:  2002-06-18       Impact factor: 3.162

6.  Searching for virulence factors in the non-pathogenic parasite to humans Leishmania tarentolae.

Authors:  H Azizi; K Hassani; Y Taslimi; H Shateri Najafabadi; B Papadopoulou; S Rafati
Journal:  Parasitology       Date:  2009-05-06       Impact factor: 3.234

7.  Mechanism of ascaridole activation in Leishmania.

Authors:  Gerald Geroldinger; Matthias Tonner; Hubert Hettegger; Markus Bacher; Lianet Monzote; Martin Walter; Katrin Staniek; Thomas Rosenau; Lars Gille
Journal:  Biochem Pharmacol       Date:  2017-03-02       Impact factor: 5.858

8.  Identification of small molecule lead compounds for visceral leishmaniasis using a novel ex vivo splenic explant model system.

Authors:  Yaneth Osorio; Bruno L Travi; Adam R Renslo; Alex G Peniche; Peter C Melby
Journal:  PLoS Negl Trop Dis       Date:  2011-02-15

9.  Comparing Leishman and Giemsa staining for the assessment of peripheral blood smear preparations in a malaria-endemic region in India.

Authors:  Sanghamitra Sathpathi; Akshaya K Mohanty; Parthasarathi Satpathi; Saroj K Mishra; Prativa K Behera; Goutam Patel; Arjen M Dondorp
Journal:  Malar J       Date:  2014-12-30       Impact factor: 2.979

10.  Leishmania tarentolae molecular signatures in a 300 hundred-years-old human Brazilian mummy.

Authors:  Shênia P C Novo; Daniela Leles; Raffaella Bianucci; Adauto Araujo
Journal:  Parasit Vectors       Date:  2015-02-04       Impact factor: 3.876

View more
  1 in total

1.  Leishmania tarentolae as an Antigen Delivery Platform: Dendritic Cell Maturation after Infection with a Clone Engineered to Express the SARS-CoV-2 Spike Protein.

Authors:  Ilaria Varotto-Boccazzi; Micaela Garziano; Giulia Maria Cattaneo; Beatrice Bisaglia; Paolo Gabrieli; Mara Biasin; Alessandro Manenti; Diego Rubolini; Mario Clerici; Emanuele Montomoli; Gian Vincenzo Zuccotti; Daria Trabattoni; Sara Epis; Claudio Bandi
Journal:  Vaccines (Basel)       Date:  2022-05-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.